Blood-Brain Barrier Peptide Transport: Research Overview
Preclinical research on blood-brain barrier peptide transport: BBB structure, exclusion mechanisms, and CNS-penetrant peptides Selank, Semax, and Pinealon.
Preclinical research on blood-brain barrier peptide transport: BBB structure, exclusion mechanisms, and CNS-penetrant peptides Selank, Semax, and Pinealon.
CJC-1295 vs Tesamorelin: compare GHRH analog structures, half-lives, GH pulse patterns, IGF-1 profiles, and body composition findings in preclinical models.
Explore Melanotan-2 CNS research: MC3R/MC4R expression, neuroprotection in TBI and ischemia models, microglial NF-κB suppression, and oxidative stress data.
Semax BDNF research: rodent brain models, VEGF expression, MCAO stroke data, and melanocortin receptor mechanisms reviewed from peer-reviewed literature.
Explore MOTS-c as an exercise mimetic in preclinical research: AMPK activation, GLUT4 translocation, PGC-1α upregulation, and metabolic effects in rodent models
Explore BPC-157 neurological research: dopaminergic, serotonergic, and GABAergic pathways, neuroprotection, and depression-like behaviour in rodent models.
Preclinical overview of GHK-Cu TB-500 tissue repair: collagen synthesis, actin sequestration, ECM remodelling, and angiogenesis in rodent wound models.
Explore preclinical research on the CJC-1295 MOTS-c stack: GH axis amplification paired with mitochondrial AMPK activation across animal model studies.
Preclinical research on the BPC-157 GHK-Cu stack examines complementary angiogenic, collagen-synthesis, and anti-fibrotic mechanisms in tissue repair models.